Abstract
In recent years female sexual dysfunction (FSD) is increasingly being recognised.
It has a detrimental effect on a woman's quality of life and includes a range of disorders,
and therefore adequate screening and diagnosis of patients are necessary before appropriate
treatment can be commenced. As the etiology of FSD is often multi-factorial, arising
from a multitude of organic pathologies in addition to having an underlying psychological
basis, the treatment is often multidisciplinary. An understanding of the etiopathogenesis
is therefore imperative to management. In the past 20 years major changes have occurred
in our understanding, conceptualization and treatment of sexual dysfunction. In this
article we look at the prevalence, classification, etiology and management of FSD.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Obstetrics and Gynecology and Reproductive BiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Sexual dysfunction in the United States: prevalence and predictors.JAMA. 1999; 281: 537-544
- The high prevalence of sexual concerns among women seeking routine gynecological care.J Fam Pract. 2000; 49: 229-232
- Frequency of sexual dysfunction in “normal” couples.N Engl J Med. 1978; 299: 111-115
- Prevalence of sexual dysfunction among mature men and women in USA, Canada, Australia and New Zealand.J Urol. 2003; 169: 315
- Problems with sexual function in people attending London general practitioners: cross sectional study.BMJ. 2003; 327: 423
- Human sexual response.Little, Brown & Co., Boston1966 ([Ref. Type: Generic])
- Report of the international consensus development conference on female sexual dysfunction: definitions and classifications.J Urol. 2000; 163: 888-893
- Female sexual response: the role of drugs in the management of sexual dysfunction.Obstet Gynecol. 2001; 98: 350-353
- Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision.J Psychosom Obstet Gynaecol. 2003; 24: 221-229
- Summary of the recommendations on sexual dysfunctions in women.J Sex Med. 2004; 1: 24-34
- Factors affecting sexual functioning of women in the mid-life years.Climacteric. 1999; 2: 254-262
- Confronting the challenges: epidemiological study of female sexual dysfunction and the menopause.J Sex Med. 2005; 2: 118-132
- Sex and the quality of life in Denmark.Arch Sex Behav. 1998; 27: 295-307
- Are changes in sexual functioning during midlife due to aging or menopause?.Fertil Steril. 2001; 76: 456-460
- Sexuality during pregnancy and the year postpartum.J Fam Pract. 1998; 47: 305-308
- Women's sexual health after childbirth.BJOG. 2000; 107: 186-195
- Rate of dyspareunia after delivery in primiparae according to mode of delivery.Eur J Obstet Gynecol Reprod Biol. 2006; 124: 42-46
- Postpartum sexual functioning and its relationship to perineal trauma: a retrospective cohort study of primiparous women.Am J Obstet Gynecol. 2001; 184: 881-888
- Distress about sex: a national survey of women in heterosexual relationships.Arch Sex Behav. 2003; 32: 193-208
- Low sexual desire in midlife and older women: personality factors, psychosocial development, present sexuality.Menopause. 2004; 11: 726-740
- Female sexuality and its disorders from the psychological viewpoint.Zentralbl Gynakol. 2000; 122: 566-570
- Is there an association between menopause status and sexual functioning?.Menopause. 2000; 7: 297-309
- Female sexual desire disorders: subtypes, classification, personality factors and new directions for treatment.World J Urol. 2002; 20: 79-88
- Turning on and turning off: a focus group study of the factors that affect women's sexual arousal.Arch Sex Behav. 2004; 33: 527-538
- Peptide histidine methionine (PHM) increases vaginal blood flow in normal women.Peptides. 1990; 11: 401-404
- Genital vascular responsiveness and sexual feelings in midlife women: psychophysiologic, brain, and genital imaging studies.Menopause. 2004; 11: 741-748
- Immunohistochemical description of nitric oxide synthase isoforms in human clitoris.J Urol. 1997; 158: 75-78
- Menopause is associated with endothelial dysfunction in women.Hypertension. 1996; 28: 576-582
- The protective effects of estrogen on the cardiovascular system.N Engl J Med. 1999; 340: 1801-1811
- Female sexual dysfunction.Urol Clin North Am. 2001; 28: 405-416
- Vasoactive intestinal polypeptide loses its ability to increase vaginal blood flow after menopause.Am J Obstet Gynecol. 1991; 164: 556-558
- Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause.Am J Obstet Gynecol. 1985; 151: 153-160
- Androgen replacement for women.Can Fam Physician. 1999; 45: 2100-2107
- The effects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials.Menopause. 2004; 11: 749-765
- The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life.J Clin Endocrinol Metab. 1999; 84: 3896-3902
- Female sexual disorders: assessment, diagnosis, and treatment.Urol Clin North Am. 2007; 34: 497-504
- Taking a sexual history.Obstet Gynecol Clin North Am. 2006; 33: 535-547
- GPs’ views on their management of sexual dysfunction.Fam Pract. 2001; 18: 516-518
- Female sexual dysfunction: are urogynecologists ready for it?.Int Urogynecol J Pelvic Floor Dysfunct. 2009; 20: 89-101
- Introduction to special issue on women's sexuality and outline of assessment of sexual problems.Menopause. 2004; 11: 709-713
- Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options.Urology. 1999; 54: 385-391
- Clinical evaluation and management strategy for sexual dysfunction in men and women.J Sex Med. 2004; 1: 49-57
- Sexual function and dysfunction in women.Psychiatr Clin North Am. 2003; 26: 673-682
- Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction.Urology. 1999; 53: 481-486
- Measurement of male and female sexual dysfunction.Curr Psychiatry Rep. 2001; 3: 182-187
- A short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12).Int Urogynecol J Pelvic Floor Dysfunct. 2003; 14: 164-168
- A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse.Am J Obstet Gynecol. 2001; 184: 552-558
- Validation of the profile of female sexual function (PFSF) in surgically and naturally menopausal women.J Sex Marital Ther. 2004; 30: 25-36
- The Arizona Sexual Experience Scale (ASEX): reliability and validity.J Sex Marital Ther. 2000; 26: 25-40
- Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder.J Sex Marital Ther. 2003; 29: 39-46
- Patient reported outcomes used in the assessment of premature ejaculation.Urol Clin North Am. 2007; 34 (vii): 581-589
- ABC of sexual health: taking a sexual history.BMJ. 1998; 317: 1573-1576
- The role of androgens in female sexual dysfunction.Mayo Clin Proc. 2004; 79: S19-S24
- Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.N Engl J Med. 2000; 343: 682-688
- Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study.BJOG. 2001; 108: 623-628
- Female orgasmic dysfunction.in: Balon R. Segraves R. Handbook of sexual dysfunction. 2005 ([Ref Type: Generic])
- Botulinum toxin in the treatment of refractory vaginismus.Obstet Gynecol. 2004; 104: 922-925
- Persistent genital arousal disorder in women: case reports of association with anti-depressant usage and withdrawal.J Sex Marital Ther. 2008; 34: 150-159
Article info
Publication history
Published online: July 12, 2010
Accepted:
June 28,
2010
Received in revised form:
June 11,
2010
Received:
February 3,
2010
Identification
Copyright
© 2010 Elsevier Ireland Ltd. Published by Elsevier Inc. All rights reserved.
